Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Patent
1984-04-06
1985-08-13
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
514253, 514495, A61K 31429, A61K 31625
Patent
active
045350787
ABSTRACT:
An antibacterial composition useful in burn therapy comprises silver sulfadiazine, sodium piperacillin and a physiologically acceptable carrier.
REFERENCES:
patent: 4112090 (1978-09-01), Saikawa et al.
"Piperacillin, a New Penicillin Active Against Many Bacteria Resistant to Other Penicillins", Fu et al., vol. 13, No. 3, Mar., 1978, Antimicrobial Agents and Chemotherapy, pp. 358-367.
Modak et al., "Control of Burn Wound Infections by Pefloxacin and its Silver Derivative", Burns, vol. 10, No. 3, pp. 170-178, (1983).
McManus et al., "Burn Wound Infection", The Journal of Trauma, vol. 21, No. 9, pp. 753-756, Sep. 1981.
Heggers et al., "Cerium Nitrate/Silver Sulphadiazine: Synergism or Antagonism as Determined by Minimum Inhibitory Concentration", Burns, vol. 5, No. 4, pp. 308-311, (1978).
Fox et al., "Virulence of Pseudomonas Infection in Burned Rats and Mice", Archives of Surgery, vol. 101, pp. 508-512, Oct. 1970.
Snelling et al., "Resistance of Gram-Negative Bacilli to Gentamicin", The Journal of Infectious Diseases, vol. 124, Supplement, pp. S264-S270, Dec. 1971.
Stone et al., "The Evolution and Spread of Gentamicin-Risistant Pseudomonads", The Journal of Trauma, vol. 11, No. 7, pp. 586-589, 1971.
Shulman et al., "Colonization with Gentamicin-Resistant Pseudomonas Aeruginosa, Pyocine Type 5, in a Burn Unit", The Journal of Infectious Diseases, vol. 124, Supplement, pp. S18-S23, Dec. 1971.
Chadwick, "Resistance of Pseudomonas Aeruginosa to Gentamicin", CMA Journal, vol. 109, pp. 585-587, Oct. 6, 1973.
Bryan et al., "Gentamicin Resistance in Pseudomonas Aeruginosa: R-Factor-Mediated Resistance", Antimicrob. Ag. Chemother., vol. 6, No. 2, pp. 191-199, Aug. 1974.
Fox, "Silver Sulfadiazine--A New Topical Therapy for Pseudomonas in Burns", Archives of Surgery, vol. 96, pp. 184-188, Feb. 1968.
Fox et al., "Control of Pseudomonas Infection in Burns by Silver Sulfadiazine", Surgery, Gynecology & Obstetrics; vol. 128, pp. 1021-1026, May, 1969.
Gayle et al., "Resistant Enterobacter Cloacae in a Burn Center: The Ineffectiveness of Silver Sulfadiazine", The Journal of Trauma, vol. 18, No. 4-5, pp. 317-323, May 1978.
Modak et al., "Silver Sulfadiazine (AgSD) Resistant Pseudomonas Infection in Experimental Burn Wounds", Estratto da Panminerva Medica Europa Medica, vol. 25, No. 3, pp. 181-188, (Jul.-Sep. 1983).
Modak et al., "Sulfadiazine Silver-Resistant Pseudomonas in Burns", Archives of Surgery, vol. 116, pp. 854-857, Jul. 1981.
Fox, Jr. Charles L.
Modak Shanta M.
Schenkman Leonard
The Trustees of Columbia University in the City of New York
LandOfFree
Antibacterial composition comprising silver sulfadiazine and sod does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial composition comprising silver sulfadiazine and sod, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial composition comprising silver sulfadiazine and sod will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2318547